Navigation Links
Frost & Sullivan Recognizes Holst Centre and imec for Its Path Breaking Wearable Energy Harvester Technology
Date:2/2/2010

p>Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Holst Centre

Holst Centre is an independent open-innovation R&D centre that develops generic technologies for Wireless Autonomous Transducer Solutions and for Systems-in-Foil. A key feature of Holst Centre is its partnership model with industry and academia around shared roadmaps and programs. It is this kind of cross-fertilization that enables Holst Centre to tune its scientific strategy to industrial needs.

Holst Centre was set up in 2005 by imec (Flanders, Belgium) and TNO (The Netherlands) with support from the Dutch Ministry of Economic Affairs and the Government of Flanders. It is named after Gilles Holst, a Dutch pioneer in Research and Development and first director of Philips Research.

Located on High Tech Campus Eindhoven, Holst Centre benefits from the state-of-the-art on-site facilities. Holst Centre has over 150 employees from around 25 nationalities and a commitment from over 20 industrial partners.

About imec

Imec performs world-leading research in nano-electronics. Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. Imec delivers industry-relevant technology solutions. In a unique high-tech environment, its international top talent is committed to providing the building blocks for a better life in a sustainable soc
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
2. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
3. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
4. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
5. Widening Application Range to Boost MRI Markets in Eastern Europe, Says Frost & Sullivan
6. Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown, Declares Frost & Sullivan
7. Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design
8. Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan
9. Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough
10. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
11. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... TheraQuest Biosciences, Inc., a clinical stage pain management company today announced ... Vice President, Pharmaceutical Development and General Counsel and Douglas R. Baum ... 2010 , TheraQuest unveiled its analgesic product pipeline and provided a status ... , , ...
... 22 OvaGene Oncology Inc., a biotechnology company specializing in ... announced today the opening of its new clinical and research laboratory ... the central headquarters for operations, research, and molecular clinical lab testing. ... The ...
Cached Medicine Technology:Two Pharmaceutical Executives Join TheraQuest Management Team 2OvaGene Oncology Opens New Innovative Gynecologic Cancer Laboratory and Research Facility 2
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... many as 10 million older Americans suffer from depression, ... , However, new research a project that followed ... six years found that Internet use among the ... than 30 percent. , "That,s a very strong effect," ... telecommunication, information studies and media who led the project. ...
(Date:4/17/2014)... Calif., April 17, 2014 By discovering a new ... after a stroke, researchers at UC Irvine and the ... that may limit or prevent stroke-induced brain damage. , ... fourth-leading cause of death and primary reason for disability ... in a stroke and lets blood-borne material into the ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... , MORRISTOWN, N.J., July 27 ... ), a leader in generic and specialty branded pharmaceuticals, announced that ... Officer, has taken a leave of absence from the Company for ... Watson, announced that R. Todd Joyce, Vice President, Corporate Controller and ...
... , , NEW YORK, July ... company developing a minimally invasive drug delivery platform for the regional treatment of ... In addition, the Company reported its financial results for the second quarter ended ... , , Screened 40 Additional Patients ...
... , SWIFTWATER, Pa., July 27 Sanofi ... SNY ), announced today that it has shipped the ... Fluzone vaccine is indicated for active immunization in people 6 months ... subtypes A and type B contained in the seasonal influenza vaccine. ...
... , , ... California Cardiothoracic Surgery Center specializes in cardiothoracic surgery including ... seem like serious symptoms. In fact, most people brush off these ... symptoms can be indications of the need for mitral ...
... , , , , ... AMGN ) reported adjusted earnings per share (EPS) of $1.29 for the ... second quarter of 2008. Adjusted net income increased 6 percent to $1,311 million ... of 2008. , , Total revenue decreased 1 percent during the ...
... , , WASHINGTON, July ... Action, the legislative lobbying arm of Family Research Council, will ... President Obama,s proposed government takeover of the health care system. ... Congressional leaders to discuss the moral, ethical, and financial dangers ...
Cached Medicine News:Health News:Watson CFO Mark W. Durand to Take Leave of Absence 2Health News:Delcath Systems Provides Update on Progress 2Health News:Delcath Systems Provides Update on Progress 3Health News:Delcath Systems Provides Update on Progress 4Health News:Delcath Systems Provides Update on Progress 5Health News:Delcath Systems Provides Update on Progress 6Health News:Delcath Systems Provides Update on Progress 7Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 2Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 3Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 4Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 5Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 6Health News:Southern California Surgical Center (heart411.com) Specializes in Mitral Valve Replacement 2Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 2Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 3Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 4Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 5Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 6Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 7Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 8Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 9Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 10Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 11Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 12Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 13Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 14Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 15Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 16Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 17Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 18Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 19Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 20Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 21Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 22Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 23
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features: Eppendorf "pipette/tip" ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 100-1,000 microliter range....
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,409-7) or contact custom...
Medicine Products: